Authors:
ARDATI A
GOTTOWIK J
HENRIOT S
CLERC RG
KILPATRICK GJ
Citation: A. Ardati et al., PHARMACOLOGICAL CHARACTERIZATION OF THE RECOMBINANT HUMAN CRF BINDING-PROTEIN USING A SIMPLE ASSAY, Journal of neuroscience methods, 80(1), 1998, pp. 99-105
Authors:
GOTTOWIK J
GOETSCHY V
HENRIOT S
KITAS E
FLUHMAN B
CLERC RG
MOREAU JL
MONSMA FJ
KILPATRICK GJ
Citation: J. Gottowik et al., LABELING OF CRF1 AND CRF2 RECEPTORS USING THE NOVEL RADIOLIGAND, [H-3] UROCORTIN, Neuropharmacology, 36(10), 1997, pp. 1439-1446
Authors:
JENCK F
MOREAU JL
MARTIN JR
KILPATRICK GJ
REINSCHEID RK
MONSMA FJ
NOTHACKER HP
CIVELLI O
Citation: F. Jenck et al., ORPHANIN FQ ACTS AS AN ANXIOLYTIC TO ATTENUATE BEHAVIORAL-RESPONSES TO STRESS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(26), 1997, pp. 14854-14858
Authors:
MURRAY PJ
HELDEN RM
JOHNSON MR
ROBERTSON GM
SCOPES DIC
STOKES M
WADMAN S
WHITEHEAD JWF
HAYES AG
KILPATRICK GJ
LARGE C
STUBBS CM
TURPIN MP
Citation: Pj. Murray et al., NOVEL 6-SUBSTITUTED 2-AMINOTETRALINS WITH POTENT AND SELECTIVE AFFINITY FOR THE DOPAMINE D-3 RECEPTOR, Bioorganic & medicinal chemistry letters, 6(4), 1996, pp. 403-408
Authors:
GARDNER CJ
ARMOUR DR
BEATTIE DT
GALE JD
HAWCOCK AB
KILPATRICK GJ
TWISSELL DJ
WARD P
Citation: Cj. Gardner et al., GR205171 - A NOVEL ANTAGONIST WITH HIGH-AFFINITY FOR THE TACHYKININ NK1 RECEPTOR, AND POTENT BROAD-SPECTRUM ANTIEMETIC ACTIVITY, Regulatory peptides, 65(1), 1996, pp. 45-53
Authors:
BOUNTRA C
GALE JD
GARDNER CJ
JORDAN CC
KILPATRICK GJ
TWISSELL DJ
WARD P
Citation: C. Bountra et al., TOWARDS UNDERSTANDING THE ETIOLOGY AND PATHOPHYSIOLOGY OF THE EMETIC REFLEX - NOVEL APPROACHES TO ANTIEMETIC DRUGS, Oncology, 53, 1996, pp. 102-109
Authors:
BROWN JD
OSHAUGHNESSY CT
KILPATRICK GJ
SCOPES DIC
BESWICK P
CLITHEROW JW
BARNES JC
Citation: Jd. Brown et al., CHARACTERIZATION OF THE SPECIFIC BINDING OF THE HISTAMINE H-3 RECEPTOR ANTAGONIST RADIOLIGAND [H-3] GR168320, European journal of pharmacology, 311(2-3), 1996, pp. 305-310
Authors:
MURRAY PJ
HARRISON LA
JOHNSON MR
ROBERTSON GM
SCOPES DIC
BULL DR
GRAHAM EA
HAYES AG
KILPATRICK GJ
DENDAAS I
LARGE C
SHEEHAN MJ
STUBBS CM
TURPIN MP
Citation: Pj. Murray et al., A NOVEL SERIES OF ARYLPIPERAZINES WITH HIGH-AFFINITY AND SELECTIVITY FOR THE DOPAMINE D-3 RECEPTOR, Bioorganic & medicinal chemistry letters, 5(3), 1995, pp. 219-222
Citation: Gj. Kilpatrick et al., 5-HT3 AND 5-HT4 RECEPTORS IN TERMINAL REGIONS OF THE MESOLIMBIC SYSTEM, Behavioural brain research, 73(1-2), 1995, pp. 11-13
Authors:
PERREN MJ
ROGERS H
MASON GS
BULL DR
KILPATRICK GJ
Citation: Mj. Perren et al., A PHARMACOLOGICAL COMPARISON OF [H-3] GRANISETRON BINDING-SITES IN BRAIN AND PERIPHERAL-TISSUES OF THE MOUSE, Naunyn-Schmiedeberg's archives of pharmacology, 351(3), 1995, pp. 221-228
Authors:
GARDNER CJ
TWISSELL DJ
GALE JD
KILPATRICK GJ
WARD P
Citation: Cj. Gardner et al., EFFECTS OF RACEMIC CP-99,994, A TACHYKININ NK1 RECEPTOR ANTAGONIST, ON MOTION-INDUCED EMESIS IN SUNCUS-MURINUS, British Journal of Pharmacology, 116, 1995, pp. 250-250
Authors:
GARDNER CJ
TWISSELL DJ
DALE TJ
GALE JD
JORDAN CC
KILPATRICK GJ
BOUNTRA C
WARD P
Citation: Cj. Gardner et al., THE BROAD-SPECTRUM ANTIEMETIC ACTIVITY OF THE NOVEL NONPEPTIDE TACHYKININ NK1 RECEPTOR ANTAGONIST GR203040, British Journal of Pharmacology, 116(8), 1995, pp. 3158-3163
Citation: J. Clapham et Gj. Kilpatrick, THIOPERAMIDE, THE SELECTIVE HISTAMINE-H-3 RECEPTOR ANTAGONIST, ATTENUATES STIMULANT-INDUCED LOCOMOTOR-ACTIVITY IN THE MOUSE, European journal of pharmacology, 259(2), 1994, pp. 107-114
Authors:
PERREN MJ
BULL DR
MULLINGS JD
KILPATRICK GJ
Citation: Mj. Perren et al., EVALUATION OF THE MOUSE ISOLATED SUPERFUSED DISTAL COLON AS A FUNCTIONAL 5-HT3 RECEPTOR-CONTAINING PREPARATION, British Journal of Pharmacology, 112, 1994, pp. 210000091-210000091
Citation: H. Rogers et al., EX-VIVO BINDING OF 5-HT3 ANTAGONISTS TO 5-HT3 RECEPTORS IN THE RAT ENTORHINAL CORTEX AND COLON, British Journal of Pharmacology, 112, 1994, pp. 210000155-210000155
Authors:
BROWN JD
OSHAUGHNESSY CT
KILPATRICK GJ
SCOPES DIC
BESWICK P
CLITHEROW JW
BARNES JC
Citation: Jd. Brown et al., CHARACTERIZATION OF THE SPECIFIC BINDING OF THE HISTAMINE H-3 RECEPTOR ANTAGONIST RADIOLIGAND [H-3] GR168320, British Journal of Pharmacology, 112, 1994, pp. 210000174-210000174
Citation: Rm. Hagan et al., INTERACTIONS BETWEEN 5-HT(3) RECEPTORS AND CEREBRAL DOPAMINE FUNCTION- IMPLICATIONS FOR THE TREATMENT OF SCHIZOPHRENIA AND PSYCHOACTIVE SUBSTANCE-ABUSE, Psychopharmacology, 112(1), 1993, pp. 190000068-190000075
Authors:
LUMMIS SCR
SEPULVEDA MI
KILPATRICK GJ
BAKER J
Citation: Scr. Lummis et al., CHARACTERIZATION OF [H-3] META-CHLOROPHENYLBIGUANIDE BINDING TO 5-HT(3) RECEPTORS IN N1E-115 NEUROBLASTOMA-CELLS, European journal of pharmacology, 243(1), 1993, pp. 7-11
Authors:
STEWARD LJ
WEST KE
KILPATRICK GJ
BARNES NM
Citation: Lj. Steward et al., LABELING OF 5-HT(3) RECEPTOR RECOGNITION SITES IN THE RAT-BRAIN USINGTHE AGONIST RADIOLIGAND [H-3] META-CHLOROPHENYLBIGUANIDE, European journal of pharmacology, 243(1), 1993, pp. 13-18
Authors:
CLAPHAM J
DENNES RP
KILPATRICK GJ
BARNES JC
Citation: J. Clapham et al., ABILITY OF THE SELECTIVE HISTAMINE H-3 RECEPTOR ANTAGONIST THIOPERAMIDE TO IMPROVE SHORT-TERM-MEMORY AND REVERSAL-LEARNING IN THE RAT, British Journal of Pharmacology, 110, 1993, pp. 160000065-160000065
Citation: Cj. Grossman et al., DEVELOPMENT OF A RADIOLIGAND BINDING ASSAY FOR 5-HT(4)-RECEPTORS IN GUINEA-PIG AND RAT-BRAIN, British Journal of Pharmacology, 109(3), 1993, pp. 618-624